Likewise, patients with OM in their plaques had significantly more OPG in their plasma compared to patients without (3.5±1.2 ng/mL vs 2.3±1.3 ng/mL, p = 0.03) (Fig. 1B). This evidence concerns the gene TNFRSF11B and ocular melanoma.